中文

广康生化 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-24
ItemAmountY/Y
Revenue¥0.16B-14.3%
Gross profit¥0.03B
Operating income¥-0.00B
Net income¥-0.00B-102.3%
Gross margin19.2%Net margin -0.2%
Revenue Q/Q-21.7%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.13B80.8%
R&D¥0.01B5.2%
SG&A¥0.02B11.9%
Tax & other¥-0.00B-0.4%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

电声股份斯迪克天迈科技久量股份华辰装备中科海讯铂科新材易天股份泰林生物中富电路玉禾田艾可蓝

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies